ALERT ATTENTION ⚠️
In observance of a holiday, Agilent CrossLab/iLab Operations Software Support Help Desk will be closed during U.S. hours on Monday, September 7th, 2026. We will resume regular U.S. support hours on Tuesday, September 8th, 2026. EU and APAC Support will remain open during this time. For urgent matters, please add "Urgent" to the ticket/email subject or press "1" when prompted to escalate a call on the iLab Support phone, and we will prioritize those requests first.
| Hours | Location |
|
Monday - Friday 9:00 AM- 6:00 PM |
3227 Broadway, L3.017 JLG New York, NY 10027 |
| Name | Role | Phone | Location | |
|---|---|---|---|---|
| Tanya Tabachnik |
Sr. Director of Scientific Platforms
|
(212) 853-0472
|
tt2564@columbia.edu
|
L3.008 JLG
|
| Darcy Peterka |
Director of Team Science
|
(212) 853 1124
|
dp2403@columbia.edu
|
|
| David Ng |
Custom Genetic Access Tools
|
(212) 853 1001
|
dn2250@columbia.edu
|
L3 Quad A JLG
|
| Susan Brenner-Morton |
Antibody Services
|
(212) 853 1001
|
sm325@columbia.edu
|
L3 Quad A JLG
|
| Molecular Tools Projects |
| ► Antibody Services (14) | |||
| Name | Description | Price | |
|---|---|---|---|
| Stock Polyclonal Antibody |
Includes chicken, rat, rabbit, or guinea pig |
Inquire | |
| Monoclonal Project Phase I: Immunization of Mice | Inquire | ||
| Monoclonal Project Phase II: Fusion of immune spleen. ELISA screen | Inquire | ||
| Monoclonal Project Phase III: Processing of ELISA positives from Phase II (custom) | Inquire | ||
| Cloning of Hybridoma from Monoclonal Project (1 round) | Inquire | ||
| Fusion Screen - Frozen Sections | Inquire | ||
| Fusion Screen Transfected Cells | Inquire | ||
| Polyclonal Project Serum Screen on Frozen Sections | Inquire | ||
| Polyclonal Project Serum Screen on Transfected Cells | Inquire | ||
| Affinity Purification of Polyclonal Serum on Immunizing Peptide | Inquire | ||
| Generation of Monoclonal Supernatant from Hybridoma | Inquire | ||
| Production of Bacterial Expression Vector for Immunogen production | Inquire | ||
| Production of Eukaryotic expression Vector | Inquire | ||
| Production of Immunogen | Inquire | ||
| ► Genetic Access Tools (8) | |||
| Name | Description | Price | |
| GAT - Custom Project | Inquire | ||
| GAT - Embryonic Stem (ES) Cell Targeting (including targeting vector) Phase III | Inquire | ||
| GAT - NEPA21 electroporations Phase III | Inquire | ||
| GAT - Pronuclear injection, CRISPR including targeting vector Phase III | Inquire | ||
| in vitro expression of construct(s) in HEK293 cells | Inquire | ||
| in vitro testing of sgRNAs with Cas9 | Inquire | ||
| in vitro transcription of guide RNA | Inquire | ||
| Maxi Prep | Inquire | ||
| ► Antibody Hourly Rate (1) | |||
| Name | Description | Price | |
| Hourly rate Antibody | Inquire | ||
| ► Genetic Access Tools Hourly Rate (2) | |||
| Name | Description | Price | |
| Hourly Rate - Genetic Access Tool - Director | Inquire | ||
| Hourly rate Genetic Access Tools Associate | Inquire | ||
| ► Virology (3) | |||
| Name | Description | Price | |
| Basic AAV construct design/optimization |
Design, optimization, and generation of custom AAV transfer vector. Final clone will be a sequence verified DNA miniprep. |
Inquire | |
| Mini AAV prep |
Small-scale AAV packaging with a volume of ~40 uL and titers ranging from 5.0E+12 - 1.0E+13 vg/mL |
Inquire | |
| Standard AAV prep |
Standard AAV packaging scale using iodixanol ultracentrifugation. Typical yield: ~140 uL and a titer >1.0E+13 vg/mL. Some capsid serotypes may, however, produce lower titers. |
Inquire | |